Bittar A E, Ratcliffe P J, Richardson A J, Raine A E, Jones L, Yudkin P L, Carter R, Mann J I, Morris P J
Nuffield Department of Surgery, Churchill Hospital, Oxford, United Kingdom.
Transplantation. 1990 Dec;50(6):987-92. doi: 10.1097/00007890-199012000-00018.
To determine the extent of persisting hyperlipidemia in renal transplant recipients receiving modern maintenance immunosuppressive and antihypertensive therapy we compared plasma levels of total and high-density lipoprotein and triglyceride in 275 renal transplant recipients with stable graft function with age- and sex-matched groups from the local general population (n = 4055). Total cholesterol and triglyceride were higher in transplanted patients in all age groups, but the difference was much more striking in women. Plasma levels of HDL cholesterol were similar or slightly lower in transplanted patients. Association with parameters of graft function, immunosuppressive therapy, and antihypertensive therapy were studied within the transplanted population using multiple regression. Total cholesterol was significantly and independently associated with age, sex, diuretic therapy, and urinary protein. In 127/134 (95%) of patients the diuretic was a loop diuretic. None of the other classes of antihypertensive drug was independently associated with serum cholesterol. The only variables significantly associated with HDL cholesterol were sex and the plasma creatinine. Plasma triglyceride was significantly and independently associated with both diuretic therapy and beta-blocker therapy and with age, urinary protein excretion, and plasma albumin. Plasma cholesterol, HDL cholesterol, and triglyceride levels were almost identical in patients receiving triple therapy (cyclosporine 3-5 mg/kg; prednisolone 7-10 mg o.d.; azathioprine 1-1.5 mg/kg) to those in patients receiving conventional immunosuppression (prednisolone 7-10 mg o.d.; azathioprine 2-2.5 mg/kg). Thus these results do not support the existence of a persisting long-term effect of cyclosporine on plasma cholesterol and triglyceride at these doses of the drug. The more striking abnormality of plasma cholesterol and triglyceride in females is unexplained but might be connected with greater sensitivity to low doses of corticosteroids.
为了确定接受现代维持性免疫抑制和抗高血压治疗的肾移植受者中持续性高脂血症的程度,我们比较了275例移植肾功能稳定的肾移植受者与当地普通人群中年龄和性别匹配组(n = 4055)的总胆固醇、高密度脂蛋白和甘油三酯的血浆水平。所有年龄组的移植患者总胆固醇和甘油三酯均较高,但女性的差异更为显著。移植患者的高密度脂蛋白胆固醇血浆水平相似或略低。在移植人群中使用多元回归研究了与移植功能参数、免疫抑制治疗和抗高血压治疗的相关性。总胆固醇与年龄、性别、利尿剂治疗和尿蛋白显著且独立相关。在127/134(95%)的患者中,利尿剂为袢利尿剂。其他种类的抗高血压药物均与血清胆固醇无独立相关性。与高密度脂蛋白胆固醇显著相关的唯一变量是性别和血浆肌酐。血浆甘油三酯与利尿剂治疗和β受体阻滞剂治疗均显著且独立相关,还与年龄、尿蛋白排泄和血浆白蛋白相关。接受三联疗法(环孢素3 - 5 mg/kg;泼尼松龙7 - 10 mg每日一次;硫唑嘌呤1 - 1.5 mg/kg)的患者与接受传统免疫抑制(泼尼松龙7 - 10 mg每日一次;硫唑嘌呤2 - 2.5 mg/kg)的患者的血浆胆固醇、高密度脂蛋白胆固醇和甘油三酯水平几乎相同。因此,这些结果不支持在这些药物剂量下环孢素对血浆胆固醇和甘油三酯存在持续的长期影响。女性血浆胆固醇和甘油三酯更显著的异常原因不明,但可能与对低剂量皮质类固醇的更高敏感性有关。